5-Norbornen-2-yl Acetate (endo- and exo- mixture)>96.0%(GC)100g

Trimethylsulphonium iodide, 95.0%, 25g

3-(3,4-DIMETHOXYPHENYL)-1-(3-HYDROXYPHENYL)-1-PROPANONE, 95.0%, 1g

1-Butyl-1-methyl-pyrrolidinium, dicyanamide, min. 98%, 100 g, glass packaging

5-Chloro-2-methoxynicotinic acid, 95.0%, 25g

N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide, 95.0%, 1g

4-Bromo-2-(4-methylpiperazin-1-yl)benzoic acid, 95.0%, 10g

(S)-tert-Butyl 3-(2-fluoro-6-nitrophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

(3S)-(+)-1-Benzyl-3-aminopyrrolidine>98.0%(GC)(T)10g

4-CHLORO-6-(TRIFLUOROMETHYL)QUINAZOLINE, 97.0%, 100mg

(2-Benzhydryloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetic acid, 97.0%, 5g

(E)-3-(4-Pentylphenyl)acrylic acid, 95%, 100mg

2-(Prop-2-yn-1-yl)pent-4-yn-1-ol, 97%, 100mg